文献

J-GLOBAL ID：201702268831043381   整理番号：17A1105344

局所限局性再発性脊索腫の管理に関するベストプラクティス:Chordoma Global Consensus Groupによる方針説明書

Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group

著者 (68件)： STACCHIOTTI S. (Fondazione IRCCS Istituto Nazionale Tumori, Milan) ,  GRONCHI A. (Fondazione IRCCS Istituto Nazionale Tumori, Milan) ,  FOSSATI P. (CNAO National Center for Oncological Hadrontherapy, Pavia) ,  FOSSATI P. (IEO European Inst. of Oncology, Milan, ITA) ,  AKIYAMA T. (Jichi Medical Univ., Saitama, JPN) ,  ALAPETITE C. (Inst. Curie, Paris) ,  ALAPETITE C. (Inst. Curie-Centre de Protontherapie d’Orsay (ICPO), Orsay, FRA) ,  BAUMANN M. (Technische Univ. Dresden, Dresden, DEU) ,  BLAY J. Y. (Centre Leon Berard, Lyon) ,  BOLLE S. (Gustave Roussy, Villejuif, FRA) ,  BORIANI S. S. (Rizzoli Inst. Bologna, Bologna) ,  BRUZZI P. (IRCCS Azienda Ospedaliera Universitaria San Martino, Genova) ,  CAPANNA R. (Univ. Clinic of Orthopedics and Traumatology AO Pisa, Pisa) ,  CARACENI A. (Fondazione IRCCS Istituto Nazionale Tumori, Milan) ,  CASADEILS R. (Rizzoli Inst. Bologna, Bologna) ,  COLIA V. (Fondazione IRCCS Istituto Nazionale Tumori, Milan) ,  DEBUS J. (Univ. Heidelberg, Heidelberg, DEU) ,  DELANEY T. (Massachusetts General Hospital, Boston, USA) ,  DESAI A. (Queen Elizabeth Hospital, Birmingham) ,  DILEO P. (Univ. Coll. London Hospitals (UCLH), London, GBR) ,  DIJKSTRA S. (Leiden Univ. Medical Centre, Leiden, NLD) ,  DOGLIETTO F. (Univ. Brescia, Brescia, ITA) ,  FLANAGAN A. (Univ. Coll. London Cancer Inst., London) ,  FLANAGAN A. (Royal National Orthopaedic Hospital NHS Trust, Stanmore, GBR) ,  FROELICH S. (Paris Diderot Univ., Paris, FRA) ,  GARDNER P. A. (Univ. Pittsburgh School of Medicine, Pittsburgh, USA) ,  GELDERBLOM H. (Leiden Univ. Medical Centre, Leiden, NLD) ,  GOKASLAN Z. L. (Brown Univ. School of Medicine, Providence, USA) ,  HAAS R. (Netherlands Cancer Inst., Amsterdam, NLD) ,  HEERY C. (National Cancer Inst., Bethesda, USA) ,  HINDI N. (Hospital Universitario Virgen del Rocio, Sevilla, ESP) ,  HOHENBERGER P. (Univ. Heidelberg, Mannheim, DEU) ,  HORNICEK F. (Harvard Medical School, Boston, USA) ,  IMAI R. (National Inst. of Radiological Sci., Chiba, JPN) ,  JEYS L. (Royal Orthopaedic Hospital Birmingham, Birmingham) ,  JONES R. L. (Royal Marsden NHS Foundation Trust and Inst. of Cancer Res., London, GBR) ,  KASPER B. (Univ. Heidelberg, Mannheim, DEU) ,  KAWAI A. (National Cancer Center, Tokyo, JPN) ,  KRENGLI M. (Univ. Piemonte Orientale, Novara, ITA) ,  LEITHNER A. (Medical Univ. Graz, Graz, AUT) ,  LOGOWSKA I. (Maria Sklodowska Curie Memorial Cancer Center and Inst. of Oncology, Warsaw, POL) ,  MARTIN BROTO J. (Hospital Universitario Virgen del Rocio, Sevilla, ESP) ,  MAZZATENTA D. (IRCCS Istituto delle Scienze Neurologiche, Bologna) ,  MOROSI C. (Univ. Brescia, Brescia, ITA) ,  NICOLAI P. (IRCCS Istituto Nazionale Tumor, Milan) ,  NORUM O. J. (Norwegian Radium Hospital, Oslo, NOR) ,  PATEL S. (MD Anderson Cancer Center, Houston, USA) ,  PENEL N. (Oscar Lambret Cancer Centre, Lille, FRA) ,  PICCI P. (Istituto Ortopedico Rizzoli, Bologna) ,  PILOTTI S. (Fondazione IRCCS Istituto Nazionale Tumori, Milan) ,  RADAELLI S. (Fondazione IRCCS Istituto Nazionale Tumori, Milan) ,  RICCHINI F. (Fondazione IRCCS Istituto Nazionale Tumori, Milan) ,  RUTKOWSKI P. (Maria Sklodowska Curie Memorial Cancer Center and Inst. of Oncology, Warsaw, POL) ,  SCHEIPL S. (Medical Univ. Graz, Graz, AUT) ,  SEN C. (NYU Langone Medical Center, New York) ,  TAMBORINI E. (Fondazione IRCCS Istituto Nazionale Tumori, Milan) ,  THORNTON K. A. (Harvard Medical School, Boston, USA) ,  TIMMERMANN B. (Univ. Hospital Essen, Essen, DEU) ,  TORRI V. (IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, ITA) ,  TUNN P. U. (HELIOS Klinikum Berlin Buch, Berlin, DEU) ,  UHL M. (Univ. Heidelberg, Heidelberg, DEU) ,  YAMADA Y. (Memorial Sloan Kettering Cancer Center, New York, USA) ,  WEBER D. C. (Paul Scherrer Inst., Villigen, CHE) ,  VANEL D. (Istituto Ortopedico Rizzoli, Bologna, ITA) ,  VARGA P. P. (National Center for Spinal Disorders, Budapest, HUN) ,  VLEGGEERT-LANKAMP C. L. A. (Leiden Univ. Medical Centre, Leiden, NLD) ,  CASALI P. G. (Fondazione IRCCS Istituto Nazionale Tumori, Milan) ,  SOMMER J. (Chordoma Foundation, Durham, USA)
資料名： Annals of Oncology  (Annals of Oncology)
巻： 28  号： 6  ページ： 1230-1242  発行年： 2017年06月 
JST資料番号： W0107A  ISSN： 0923-7534  CODEN： ANONE2  資料種別： 逐次刊行物 (A)
記事区分： 文献レビュー  発行国： イギリス (GBR)  言語： 英語 (EN)

抄録/ポイント： ESMO(欧州臨床腫瘍学会)とChordoma Founda...

シソーラス用語： *脊索腫 ,...
準シソーラス用語： *局所限局性再発性脊索腫 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1105344&from=J-GLOBAL&jstjournalNo=W0107A") }}

分類 (2件)： 運動器系の腫よう  (GG04000A) ,  腫ようの治療一般  (GE03031L)

引用文献 (76件)：

• Flanagan AM, Yamaguchi T, Chordoma. In Fletcher CDM, Bridge JA, Pancras CW, Mertens F (eds), World Health Organization (WHO) Classification of Tumours of Soft Tissue and Bone. Pathology and Genetics . Lyon: IARC Press 2013; 328-329.
• Stacchiotti S, Sommer J on behalf of a Chordoma Global Consensus Group. Building a global consensus approach to chordoma: a position paper from the medical and patient community. Lancet Oncol 2015; 16: 71-83.
• Weber DC, Malyapa R, Albertini F et al. Long term outcomes of patients with skull-base low-grade chondrosarcoma and chordoma patients treated with pencil beam scanning proton therapy. Radiother Oncol 2016; 120: 169-174.
• Tzortzidis F, Elahi F, Wright D et al. Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas. Neurosurgery 2006; 59: 230-237.
• Cloyd JM, Acosta FLJr, Polley MY et al. En bloc resection for primary and metastatic tumors of the spine: a systematic review of the literature. Neurosurgery 2010; 67: 435-444.

タイトルに関連する用語 (4件)： 再発 ,  脊索腫 ,  ベストプラクティス ,  説明書